Wyoming’s attorney general, through a settlement with a French multinational pharmaceutical and healthcare company, has ...

Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat ...

You're not able to count on it for as long as expected, say experts who call the risk high. Here's who's affected—possibly ...

While pharmacy benefits managers have been touted for their ability to save costs, their operations may actually contribute ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

In a second letter to users of MiniMed 600 and 700 series insulin pumps, the company advises patients to carry backup ...

According to Research by SNS Insider, The Human Insulin Market is projected to grow at a CAGR of 3.4%, fueled by regulatory reforms and the launch of biosimilars.Pune, Oct. 10, 2024 (GLOBE NEWSWIRE) - ...

Results from a new study suggest a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could ...

It said the companies illegally kept lower priced insulin products off their lists of approved drugs, driving up costs for consumers. The agency brought its case in its own administrative court.

accusing them of inflating the price of insulin and blocking patient access to lower-priced products. The suit came after the agency filed a critical report on the PBM industry in July that ...

Mankind Pharma focuses on specialty business, expanding therapeutic segments and plugging gaps in competitive market.

Wyoming’s attorney general, through a settlement with a French multinational pharmaceutical and health care company, has ...